Doing More With Less: Review of Dolutegravir-Lamivudine, a Novel Single-Tablet Regimen for Antiretroviral-Naïve Adults With HIV-1 Infection.

Barbara A. Santevecchi,Stacy Miller,Lindsey M. Childs-Kean

Doing More With Less: Review of Dolutegravir-Lamivudine, a Novel Single-Tablet Regimen for Antiretroviral-Naïve Adults With HIV-1 Infection.

2020

Barbara A. Santevecchi
Stacy Miller
Lindsey M. Childs-Kean

Objective: To review data on efficacy and safety of dolutegravir (DTG) and lamivudine (3TC) in treatment-naive adults with HIV-1 infection. Data Sources: Phase III clinical trials and review articl...

Keywords:

Anesthesia
Diabetes mellitus
human immunodeficiency virus
Lamivudine
antiretroviral naive
Dolutegravir
Clinical trial
HIV/AIDS
Medicine
Phases of clinical research
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations